We value your privacy

We use cookies to enhance your browsing experience, serve personalized content, and analyze our traffic. By clicking "Accept All", you consent to our use of cookies. Cookie Policy. By using this site you agree to our Terms and Conditions.

ortex-logo-h
​
​
Nasdaq:SMMT
​
​
logo

Summit Therapeutics Inc. (SMMT)

Nasdaq • SMMT • US86627T1088

16.33Last close
Market Closed
Overview
Fundamentals
Events
News
Corp Actions
Index
Analysts
EPS Momentum
Holders
Dividend
Options
Shorts
Insiders
Peers
Commodity Exp
Trading Signals
Stock Scores

ORTEX Data Highlights

As of Oct 22, 2026, ORTEX estimated 27.2% of free float sold short, 5.9 days to cover, cost to borrow 0.69%. Sign up for live short interest data.

Market Cap

13.1b USD | # 1348 in US

Volume

6.23m shares | 97.72m USD

Shares Outstanding

799.76m

Free Float Shares

19.29% | 154.3m

News

SMMT key data

Summit Therapeutics Inc. (Nasdaq: SMMT) has a market capitalization of $13.07B. Last close $16.33 (as of 2026-11-09); 52-week range $12.07 to $29.23. ORTEX data as of 2026-10-22: short interest was 27.17% of free float, 5.9 days to cover and the average cost to borrow was 0.69%. Sign up for live short interest data.

Latest on SMMT

  • Jun 10, 2026SMMT CEO Buys Ahead of Today's Print
All SMMT news on ORTEX News
  • SMMT news on ORTEX News
  • ORTEX News
  • ORTEX public data
  • ORTEX Charts
  • ORTEX API

© 2026 ORTEX Technologies Ltd.